Minoryx Therapeutics raised €51M in a Series C round in May 2022. The company is based in Matar√≥, Spain. Investors in the round: Caixa Capital Risc, Columbus Venture Partners, FundPlus and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €51M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
